By Paul McClure Clinical trials using orally administered gold nanoparticles produced promising results in treating neurodegenerative diseasesOriginal images: Clene Nanomedicine Phase 2 clinical trials using orally administered gold nanocrystals to treat multiple sclerosis and Parkinson’s disease have produced promising results, restoring metabolites linked to crucial energy activity in the brain that are depleted in these neurodegenerative...
